Advertisement
外匯新聞
Aldeyra Therapeutics Gets CRL From FDA For NDA Of ADX-2191 To Treat Primary Vitreoretinal Lymphoma
Biotechnology company Aldeyra Therapeutics, Inc. (ALDX) announced Wednesday the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the 505(b)(2) New Drug Application (NDA) of ADX-2191 (methotrexate for injection, USP), an investigational drug candidate, for the treatment of primary vitreoretinal lymphoma (PVRL).
RTTNews |
693天前
Powell Expects Further Rate Hikes As Inflation Remains Stubbornly Elevated
Following last week's widely expected pause, the Federal Reserve is likely to resume raising interest rates later this year, Fed Chair Jerome Powell said during testimony before the House Financial Services Committee on Wednesday.
RTTNews
|
693天前
DiaMedica Therapeutics Says FDA Lifts Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
Biopharmaceutical company DiaMedica Therapeutics Inc. (DMAC) announced Wednesday that the U.S. Food and Drug Administration (FDA) has removed the clinical hold placed on the investigational new drug application for its ReMEDy2 phase 2/3 clinical trial studying DM199 in the treatment of acute ischemic stroke (AIS).
RTTNews
|
693天前
Bay Street Likely To See Subdued Start
Canadian shares are likely to open on a somewhat subdued note on Wednesday, amid a lack of positive triggers.
RTTNews
|
693天前
Winnebago Industries Q3 Net Profit Halves, But Adj. EPS Tops Estimates
Recreation vehicles maker Winnebago Industries, Inc. (WGO) reported on Wednesday that third-quarter net income plunged to $59.1 million or $1.71 per share from $117.2 million or $3.57 per share in the prior-year quarter.
RTTNews
|
693天前
Pound Drops On Rate Hike Worries After Strong Inflation Data
The pound fell against its major rivals in the European session on Wednesday, as the nation's inflation came in well above consensus expectations in May, raising concerns about a bigger rate hike from the Bank of England at the monetary policy decision on Thursday.
RTTNews
|
693天前
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
693天前
more news
Sensex, Nifty End At Record Highs Despite Weak Global Cues
Indian shares eked out modest gains on Wednesday despite weak cues from global markets.
RTTNews
|
693天前
Twitter Sued By Employees Over Promised But Unpaid Bonuses
Twitter Inc. employees have sued the social media major for allegedly refusing to pay 2022 bonuses, even after promising to pay 50 percent of targeted bonus. In a lawsuit filed in San Francisco federal court, the current and former Twitter employees claim that in the months leading up to Elon Musk's acquisition of Twitter in October 2022, the company's executives, including former Chief Financial.
RTTNews
|
693天前
European Shares Subdued With UK Inflation Data In Focus
European stocks were flat to slightly lower on Wednesday, as investors reacted to stronger than expected U.K. inflation data and awaited Federal Reserve chairman Jerome Powell's testimony before the House Financial Services Committee and the Senate Banking Committee.
RTTNews
|
693天前
FTSE 100 Little Changed After Inflation Data
U.K. stocks were little changed on Wednesday after data showed U.K. consumer prices logged a steady growth rather than a slowdown in May.
RTTNews
|
693天前
Stable UK Inflation Warrants Bold Action From Bank Of England
UK consumer prices logged a steady growth rather than a slowdown in May and core inflation accelerated further adding pressure on the Bank of England to raise the benchmark rate by half a percentage point. Consumer price inflation remained unchanged at 8.7 percent in May, the Office for National Statistics reported Wednesday. The rate was forecast to ease to 8.4 percent.
RTTNews
|
693天前
CAC 40 Subdued On China Concerns
French stocks were subdued on Wednesday as investors awaited Fed Chair Jerome Powell's remarks in front of Congress later in the day for clues on the monetary policy outlook.
RTTNews
|
693天前
Stay up to date!
Add 新聞 to your browser
Add To Chrome
